Livzon Pharmaceutical Group Inc (000513) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.040x

Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥625.70 Million ≈ $91.56 Million USD) by net assets (CN¥15.79 Billion ≈ $2.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Livzon Pharmaceutical Group Inc for the company's overall valuation and market capitalisation.

Livzon Pharmaceutical Group Inc - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Livzon Pharmaceutical Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Livzon Pharmaceutical Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their cash flow conversion efficiency. Explore Livzon Pharmaceutical Group Inc (000513) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
GQG Partners Inc AU:GQG	0.528x
Primarius Technologies Co. Ltd. A SHG:688206	N/A
Hanesbrands Inc NYSE:HBI	0.062x
Doosan Fuel Cell Co Ltd KO:336260	-0.054x
By health SHE:300146	0.025x
Liveramp Holdings Inc NYSE:RAMP	0.017x
AstraZeneca PLC LSE:AZN	0.057x
Pengxin International Mining Co Ltd SHG:600490	0.073x

Annual Cash Flow Conversion Efficiency for Livzon Pharmaceutical Group Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Livzon Pharmaceutical Group Inc from 1998 to 2025. View Livzon Pharmaceutical Group Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥15.79 Billion ≈ $2.31 Billion	CN¥3.18 Billion ≈ $465.18 Million	0.201x	+0.75%
2024-12-31	CN¥14.91 Billion ≈ $2.18 Billion	CN¥2.98 Billion ≈ $435.90 Million	0.200x	-9.17%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥3.25 Billion ≈ $475.42 Million	0.220x	+18.52%
2022-12-31	CN¥14.94 Billion ≈ $2.19 Billion	CN¥2.77 Billion ≈ $405.73 Million	0.186x	+39.65%
2021-12-31	CN¥14.31 Billion ≈ $2.09 Billion	CN¥1.90 Billion ≈ $278.37 Million	0.133x	-16.09%
2020-12-31	CN¥13.64 Billion ≈ $2.00 Billion	CN¥2.16 Billion ≈ $316.19 Million	0.158x	+10.04%
2019-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥1.77 Billion ≈ $258.59 Million	0.144x	+33.44%
2018-12-31	CN¥11.75 Billion ≈ $1.72 Billion	CN¥1.27 Billion ≈ $185.49 Million	0.108x	-7.90%
2017-12-31	CN¥11.23 Billion ≈ $1.64 Billion	CN¥1.32 Billion ≈ $192.55 Million	0.117x	-34.93%
2016-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥1.28 Billion ≈ $187.19 Million	0.180x	-6.67%
2015-12-31	CN¥4.81 Billion ≈ $703.84 Million	CN¥927.79 Million ≈ $135.76 Million	0.193x	+9.77%
2014-12-31	CN¥4.08 Billion ≈ $597.39 Million	CN¥717.39 Million ≈ $104.98 Million	0.176x	+43.96%
2013-12-31	CN¥3.60 Billion ≈ $527.45 Million	CN¥439.99 Million ≈ $64.38 Million	0.122x	-34.65%
2012-12-31	CN¥3.18 Billion ≈ $465.35 Million	CN¥593.96 Million ≈ $86.92 Million	0.187x	-20.57%
2011-12-31	CN¥3.01 Billion ≈ $440.69 Million	CN¥708.20 Million ≈ $103.63 Million	0.235x	-2.00%
2010-12-31	CN¥2.64 Billion ≈ $386.19 Million	CN¥633.30 Million ≈ $92.67 Million	0.240x	+7.91%
2009-12-31	CN¥2.23 Billion ≈ $325.65 Million	CN¥494.88 Million ≈ $72.42 Million	0.222x	+18.18%
2008-12-31	CN¥1.83 Billion ≈ $268.45 Million	CN¥345.18 Million ≈ $50.51 Million	0.188x	+50.71%
2007-12-31	CN¥1.99 Billion ≈ $291.33 Million	CN¥248.55 Million ≈ $36.37 Million	0.125x	-20.69%
2006-12-31	CN¥1.44 Billion ≈ $210.51 Million	CN¥226.46 Million ≈ $33.14 Million	0.157x	+21.03%
2005-12-31	CN¥1.24 Billion ≈ $181.22 Million	CN¥161.07 Million ≈ $23.57 Million	0.130x	-16.00%
2004-12-31	CN¥1.17 Billion ≈ $171.49 Million	CN¥181.46 Million ≈ $26.55 Million	0.155x	-39.38%
2003-12-31	CN¥1.17 Billion ≈ $171.87 Million	CN¥300.01 Million ≈ $43.90 Million	0.255x	+35.12%
2002-12-31	CN¥1.13 Billion ≈ $165.38 Million	CN¥213.65 Million ≈ $31.26 Million	0.189x	+25.81%
2001-12-31	CN¥1.03 Billion ≈ $151.09 Million	CN¥155.15 Million ≈ $22.70 Million	0.150x	+277.27%
2000-12-31	CN¥967.05 Million ≈ $141.51 Million	CN¥38.52 Million ≈ $5.64 Million	0.040x	-84.25%
1999-12-31	CN¥973.90 Million ≈ $142.51 Million	CN¥246.23 Million ≈ $36.03 Million	0.253x	+1449.54%
1998-12-31	CN¥972.07 Million ≈ $142.24 Million	CN¥-18.21 Million ≈ $-2.66 Million	-0.019x	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.29 Billion

CN¥15.63 Billion CNY

Market Cap Rank

#5702 Global

#1048 in China

Share Price

CN¥26.58

Change (1 day)

-1.56%

52-Week Range

CN¥25.97 - CN¥39.69

All Time High

CN¥1418.81